➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Mallinckrodt
Merck
Johnson and Johnson
Moodys

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,737,051

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,737,051 protect, and when does it expire?

Patent 10,737,051 protects GENOSYL and is included in one NDA.

This patent has seven patent family members in five countries.

Summary for Patent: 10,737,051
Title:Nitrogen dioxide storage device
Abstract: A nitric oxide delivery system can include a cassette which is a single use disposable component used to store liquid N.sub.2O.sub.4, activate upon operator demand, convert N.sub.2O.sub.4 to NO.sub.2 via a heating element(s) controlled by a console to deliver NO.sub.2 at a controlled flow rate, direct concentrated NO.sub.2 to a contained pair of conversion cartridges and exhaust NO gas to the console for delivery to the patient.
Inventor(s): Gellman; Barry N. (Melbourne, FL), Tajudeen; Eddie (Orlando, FL), Gamero; Lucas (Oviedo, FL), Hopkins; Joshua (Orlando, FL), Bromberg; Edward E. A. (Orlando, FL), Denton; Ryan (Cocoa, FL), Johnson; Bryan J. (Orlando, FL), Fine; David (Cocoa, FL)
Assignee:
Application Number:16/283,724
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 10,737,051

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Vero Biotech GENOSYL nitric oxide GAS;INHALATION 202860-001 Dec 20, 2019 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,737,051

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015336028   Start Trial
Australia 2020260499   Start Trial
Canada 2965159   Start Trial
European Patent Office 3209360   Start Trial
Japan 2017534422   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Dow
Johnson and Johnson
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.